Back

Complications in CRT-P and CRT-D implantations: Analysis of quality assurance data from the state of North Rhine-Westphalia 2010-2020

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Poster session (2): device therapy Device Complications and Lead Extraction EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Ms Zana Karosiene

Cardiology Group Practice, Bochum (Germany)

213 More presentations in this session

Presentation thumbnail
Genetic variants and device upgrade in young pacemaker recipients
Doctor J. Sanchez Moreno (Almeria, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy
Doctor A. Sahin (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Experiences with implantable loop recorders in syncope patients
Mr A. Oinonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Forcecardiography as a non-invasive predictor of echocardiographic parameters in patients undergoing cardiac resynchronization therapy: a preliminary study
Doctor V. Pergola (Naples, IT)
Abstract
Presentation thumbnail
Diagnostic work-up and clinical characteristics in out-of-hospital cardiac arrest survivors with ICD implantation: a prospective Danish study
Mr C. Hansen (Copenhagen, DK) Doctor B. Winkel (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session (2): device therapy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Frequency of complications depending on the CIED type and the hospital's implantation spectrum: a subgroup analysis of 250,000 cases
thumbnail
Congress Presentation
Nine-year single-center audit of cardiac implantable electronic device (CIED) procedures and operator-specific outcomes
thumbnail
Congress Presentation
Volume-outcome relationship (VOR) of complications in cardiac implantable electronic device (CIED) implantation. Evaluation of 250,000 patients from external quality assurance from 2010 to 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources